ATRAPOS THERAPEUTICS
Atrapos Therapeutics develops immunomodulatory therapeutics for the management of diseases originating from overactive immune responses. Atrapos targets STAT6 protein, a key nexus in the dysregulation of immune cell-driven allergic diseases. Other targets upstream of STAT6 that contribute to this dysregulation are currently targeted by FDA-approved therapeutics for the treatment of some of these allergic diseases.
ATRAPOS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Houston, Texas, United States
Country:
United States
Status:
Active
Similar Organizations
Aardvark Therapeutics
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
Atlas Regeneration
Atlas Regeneration is developing pioneering bioinformatics solutions for regenerative medicine.
CILcare
CILcare specializes in providing drug solutions for hearing and ear disorders.
DeckTherapeutic
DeckTherapeutics specializes in acute omega-3 fatty acid therapeutics for neuroprotection.
Genpathway, Inc.
Genpathway, Inc. is specializes in providing complete service solutions for the genome-wide analysis of epigenetic events.
Interstate Optical
Interstate Optical specializes in providing high-quality lab services including unique and innovative growth resources.
Medallion Therapeutics
Medallion Therapeutics specializes in drug and biologics delivery solutions.
Sanofi Oncology
Sanofi develops and distributes therapeutic solutions for patient's needs.
StoreMyTumor
StoreMyTumor specializes in tumor preservation, advanced testing, and immune-therapy.
Transposon Therapeutics
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
More informations about "Atrapos Therapeutics"
Atrapos Therapeutics - Crunchbase Company Profile
Atrapos Therapeutics develops immunomodulatory therapeutics for the management of diseases originating from overactive immune responses. …See details»
Atrapos Therapeutics - Drug pipelines, Patents, Clinical trials
Explore Atrapos Therapeutics with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Atrapos Therapeutics LLC - Drug pipelines, Patents, Clinical
Explore Atrapos Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Immune System Diseases, Technology Platform:Small molecule drug, …See details»
Atrapos Therapeutics - VentureRadar
Atrapos Therapeutics is developing targeted immunomodulatory therapeutics for management of diseases originating from overactive immune responses. The lead molecule has demonstrated …See details»
Atropos Therapeutics - Crunchbase Company Profile
Organization. Atropos Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Atropos Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing …See details»
Atrapos Therapeutics, LLC - Company Profile - Corporation Wiki
Atrapos Therapeutics, LLC Overview. Atrapos Therapeutics, LLC filed as a Domestic Limited Liability Company (LLC) in the State of Texas on Thursday, July 16, 2015 and is …See details»
Atrapos Therapeutics - Crunchbase
Atrapos Therapeutics specializes in developing therapeutic solutions for auto-immune disorders.See details»
Atrapos Therapeutics Company Profile | Management and
Find contact information for Atrapos Therapeutics. Learn about their Business Services market share, competitors, and Atrapos Therapeutics's email format.See details»
Atrapos Therapeutics, LLC :: Texas (US) :: OpenCorporates
Jul 16, 2015 Free and open company data on Texas (US) company Atrapos Therapeutics, LLC (company number 0802254773), 3900 ESSEX LN STE 1200, HOUSTON, TX, 77027 …See details»
Atrapos Therapeutics - Overview, News & Similar companies
Aug 13, 2020 Who is Atrapos Therapeutics. Founded in 2018, Atropos is a biotechnology platform company focused on the discovery, development, and commercialization of therapies …See details»
Bios - Atropos Therapeutics
Pauline was also a founding member of the Biotechnology Industry Organization’s Business Development Advisory Committee and launched the BIO Business Development …See details»
Atropos Therapeutics Company Profile 2024: Valuation, Funding ...
Atropos Therapeutics General Information Description. Developer of anti-aging drugs designed to treat age-related diseases and cancer. The company's drugs are discovered to improve …See details»
Atrapos Therapeutics - Company Profile - Tracxn
Atrapos Therapeutics - Therapeutic solutions for auto-immune disorders. Atrapos Therapeutics has 376 competitors. Atrapos Therapeutics - Company Profile - TracxnSee details»
Atrapos Therapeutics, LLC | SBIR.gov
Asthma a chronic disease of the lungs that affects adults and children of all ages has markedly increased in incidence prevalence and severity over the past several decades with a …See details»
Working at Atrapos Therapeutics: 2 Reviews - Indeed
Reviews from Atrapos Therapeutics employees about Atrapos Therapeutics culture, salaries, benefits, work-life balance, management, job security, and more.See details»
Atrapos Therapeutics | VentureRadar
Atrapos Therapeutics is developing targeted immunomodulatory therapeutics for management of diseases originating from overactive immune responses. The lead molecule has demonstrated …See details»
PM-43I - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 29, 2024 Bone erosion in rheumatoid arthritis (RA) is partly caused by excessive activation of osteoclasts. Osteoclasts can be derived from RA synovium and their differentiation can be …See details»
Atrapos Therapeutics - VentureRadar
Similar Companies: Siolta Therapeutics USA Privately Held Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic …See details»